Clinical and Fundamental Aspects of Prosthetics and Translocation of Mitral Valve Chordae
Degenerative Mitral Valve Disease
About this trial
This is an interventional treatment trial for Degenerative Mitral Valve Disease focused on measuring Mitral Valve Chordae, Degenerative Mitral Valve Disease, Mitral Valve Chordae Replacement, Mitral Valve Chordae Translocation, Mitral Valve Chordae Prosthetics
Eligibility Criteria
Inclusion Criteria:
- Isolated type II mitral valve insufficiency by A. Carpentier
- Mitral regurgitation degree >2
- Age >18 years
- Signed informed consent to participate in the study
Exclusion Criteria:
- Any other cardiac surgeries
- Age <18 years
- Multiple organ failure
- ReDo procedure
- Persistent atrial fibrillation
- Acute infective endocarditis
- Refusal to sign informed consent
Sites / Locations
- Cardiology Research Institute, Tomsk NRMC
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Mitral valve chordae prosthesis
Mitral valve chordae translocation
Patients of this group receive mitral valve chordae replacement performed in five stages: Measure the required length of the chordae. Forming loops. Fixation of the loop group to the papillary muscles. Fixation of chordal loops to the free edge of the valve. Annuloplasty with a support ring and a hydraulic test to confirm the absence of prolapse.
The technique of translocation of secondary chordae: The method consists essentially of three stages: Selection of the secondary chordae. Fixation of secondary chordae to the free edge of the valve. Annuloplasty support ring and hydraulic test to confirm the absence of prolapse.